Dysphagia, Safety, and Effectiveness of the RefluxStop Procedure in GERD Patients With Ineffective Esophageal Motility (IEM)
Joerg Zehetner, Dino Kröll, Yannick Fringeli, Ioannis Linas, Sarah Gerber, Yves BorbélyBackground:
Patients with gastroesophageal reflux disease (GERD) and ineffective esophageal motility (IEM) do not have optimal outcomes today. With standard-of-care antireflux procedures, dysphagia often worsens. RefluxStop treats acid reflux via a novel mechanism without encircling the esophagus. This study assesses dysphagia, safety, and efficacy of the RefluxStop procedure in subjects with IEM for up to 3 years.
Methods:
Clinical outcomes of RefluxStop in two IEM-GERD cohorts were evaluated retrospectively, in a combined investigator-initiated study at University Inselspital and Hirslanden Clinic Beau-Site in Switzerland. The primary outcome was incidence of dysphagia. The secondary outcomes included improvement in GERD Health-Related Quality of Life (GERD-HRQL), food passageway-related events, and serious procedure- or device-related adverse events (ie, SAEs, SADEs).
Results:
Sixty (n=60) consecutive subjects with IEM underwent the RefluxStop procedure, with a follow-up ranging between 3 and 47 months (mean 13 mo). Median (Q25-Q75) improvement in GERD-HRQL score was 89% (83% to 96%) with statistical significance (
Conclusions:
RefluxStop surgical management for GERD was used in patients with IEM (n=60), a group which currently has no optimal treatment, and maintained favorable results for up to 3 years with excellent improvement of GERD-HRQL score (median 89%) and dysphagia (86% resolved or improved at 1y).